Hemostatic and thrombotic markers in patients with hemoglobin E/β-thalassemia disease

American Journal of Hematology

Volumn 82, Issue 11, 2007, Pages 1001-1004

  Angchaisuksiri, Pantep ^a   Atichartakarn, Vichai ^a   Aryurachai, Katcharin ^a   Archararit, Napaporn ^a   Chuncharunee, Suporn ^a   Tiraganjana, Arjit ^a   Rattanasiri, Sasivimol ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BETA2 THROMBOGLOBULIN; C REACTIVE PROTEIN; FIBRINOGEN; GLOBULIN; HEMOGLOBIN E; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTEIN S; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BETA THALASSEMIA; BLOOD CLOTTING; CELL DAMAGE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; MALE; OVARY INFLAMMATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SPLENECTOMY; THAILAND; THROMBOCYTE ACTIVATION; THROMBOSIS;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BLOOD COAGULATION FACTOR INHIBITORS; BLOOD COAGULATION FACTORS; CASE-CONTROL STUDIES; FEMALE; HEMOGLOBIN E; HEMOSTASIS; HUMANS; MALE; SPLENECTOMY;

EID: 35548988928     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20945     Document Type: Article

References (31)

1. Fucharoen S, Winichagoon P, Siritanaratkul N, Chowthaworn J, Pootrakul P. α-and β-thalassemia in Thailand. Ann NY Acad Sci 1998;850:412-414.
2. Vichinsky EP. Changing patterns of thalassemia worldwide. Ann NY Acad Sci 2005;1054:18-24.
3. Gillis S, Cappellini MD, Goldfarb A, Ciceri L, Fiorelli G, Rachmilewitz EA. Pulmonary thromboembolism in thalassemia intermedia patients. Haematologica 1999;84:957-958.
4. Wong V, Yu Y, Laing RHS, Tso WK, Li AMC, Chan TK. Cerebral thrombosis in β-thal/Hb E disease. Stroke 1990;21:812-816.
5. Borgna Pignatti C, Carnelli V, Caruso V, et al. Thromboembolic events in β thalassemia major: An Italian multicenter study. Acta Haematol 1998;99:76-79.
6. Michaeli J, Mittelman M, Grisaru D, Rachmilewitz EA. Thromboembolic complications in β thalassemia major. Acta Haematol 1992;87:71-74.
7. Cappellini MD, Robbiolo L, Bottasso BM, Coppola R, Fiorelli G, Mannucci AP. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol 2000;111:467-473.
8. Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood 2002;99:36-43.
9. Opartkiattikul N, Funahara Y, Fucharoen S, Talalak P. Increase in spontaneous platelet aggregation in β-thalassemia/hemoglobin E disease: A consequence of splenectomy. Southeast Asian J Trop Med Public Health 1981;12:36-41.
10. Eldor A, Lellouche F, Goldfarb A, Rachmilewitz EA, Maclouf J. In vivo platelet activation in β-thalassemia major reflected by increased platelet - thromboxane urinary metabolites. Blood 1991;77:1749-1753.
11. Del Principe D, Menichelli A, Di Giulio S, De Matteis W, Cianciulli P, Papa G. PADGEM/GMP-140 expression on platelet membranes from homozygous β thalassemic patients. Br J Haematol 1993;84:111-117.
12. Cappellini MD, Grespi E, Cassineho E, Bignamini D, Fiorelli G. Coagulation and splenectomy: An overview. Ann NY Acad Sci 2005;1054:317-324.
13. Shirahata A, Funahara Y, Opartkiattikul N, Fucharoen S, Laosombat V, Yamada K. Protein C and protein S deficiency in thalassemic patients. Southeast Asian J Trop Med Public Health 1992;23:65-73.
14. Musumeci S, Leonardi S, Di Dio R, Fischer A, Di Costa G. Protein C and antithrombin III in polytransfused thalassemic patients. Acta Haematol 1997;77:30-33.
15. Leonardi S, Arcidiacono G, Colianni R, DiGregorio L, Musumeci S. Protein C, protein S, and antithrombin III in thrombotic disease. Their role in β-thalassemia major. Ann NY Acad Sci 1990;612:549-552.
16. Eldor A, Durst R, Hy-Am E, et al. A chronic hypercoagulable state in patients with β-thalassemia major is already present in childhood. Br J Haematol 1999;107:739-746.
17. Livrea MA, Tesoriere L, Maggio A, D'Arpa D, Pintaudi AM, Pedone E. Oxidative modification of low-density lipoprotein and atherogenetic risk in β-thalassaemia. Blood 1998;92:3936-3942.
18. Atichartakarn V, Angchaisuksiri P, Aryuchai K, et al. Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/β-thalassaemic patients. Br J Haematol 2002;118:893-898.
19. Yashar VB-B, Barenholz Y, Hy-Am E, Rachmilewitz EA, Eldor A. Phosphatidylserine in the outer leaflet of red blood cells from β-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol 1993;44:63-65.
20. Ruf A, Pick M, Deutsch V, et al. In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with β-thalassemia major. Br J Haematol 1997;98:51-56.
21. Clauss A. Gerinnungs physioligische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957;17:237-246.
22. Kutlar A, Kutlar F, Wilson JB, Headlee MG, Huisman TH. Quantitation of hemoglobin components by high performance cation-exchange liquid chromatography. Am J Hematol 1984;17:39-53.
23. Forman DT, Parker SL. The measurement and interpretation of serum ferritin. Ann Clin Lab Sci 1980;10:345-350.
24. Stata Corp 1999. Statistical Software: Release 6.0. College Station, TX: Stata Corporation; 1999.
25. Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993;82:513-520.
26. Wolbink GJ, Brouwer MC, Buysmann S, ten Berge IJM, Hack CE. CRP-mediated activation of complement in vivo: Assessment by measuring circulating complement-C-reactive protein complexes. J Immunol 1996;157: 473-479.
27. Volanakis JE, Narkates AJ. Interaction of C-reactive protein with artificial phosphatidyl-choline bilayers and complement. J Immunol 1981;126:1820-1825.
28. Juhan-Vague I, Alessi MC, DeClerk PJ. Pathophysiology of fibrinolysis. Bailliere's Clin Haematol 1995;8:329-343.
29. Visudhiphan S, Ketsa-Ard K, Tumliang S, Piankijagum A. Significance of blood coagulation and platelet profiles in relation to pulmonary thrombosis in β-Thalassemia/Hb E. Southeast Asian J Trop Med Public Health 1994;25: 449-456.
30. Butthep P, Bunyaratvej A, Funahara Y, et al. Alterations in vascular endothelial cell-related plasma proteins in thalassemic patients and their correlation with clinical symptoms. Thromb Haemost 1995;74:1045-1049.
31. Butthep P, Rummavas S, Wisedpanichkij R, Jindadamrongwech S, Fucharoen S, Bunyaratvej A. Increased circulating activated endothelial growth factor, and tumor necrosis factor in thalassemia. Am J Hematol 2002;70: 100-106.